Abstract:Background: Hypoxia is a hallmark of the physical microenvironment of solid tumors. As a key factor that regulates tumor development and progression, hypoxia can reprogram the expression of multiple genes, whose biological function and molecular mechanism in cancer remain largely unclear. The mitochondrial ribosome protein family consists of nuclear-encoded mitochondrial proteins that are responsible for protein synthesis in the mitochondria. Methods: A high-throughput RNA sequencing assay was carried out to identify differentially expressed mRNAs between breast cancer tissues and adjacent normal tissues as well as breast tumors with metastasis and those without metastasis. Our clinical samples and TCGA database were analyzed to observe the clinical value of mitochondrial ribosome protein L52 (MRPL52) in human breast cancer. Potent hypoxia response elements in the promoter region of MRPL52 were identified and validated by chromatin immunoprecipitation and luciferase reporter assays. Functional experiments were performed using breast cancer cell lines with MRPL52 ectopic expression and knockdown cultured in a 20% or 1% O2 environment. Results: MRPL52 expression was upregulated in human breast cancer and was significantly associated with aggressive clinicopathological characteristics and a higher metastatic risk of breast cancer patients. We found that the overexpression of MRPL52 in breast cancer is induced by hypoxia-inducible factor-1 in response to hypoxic exposure. The role of MRPL52 in suppressing apoptosis and promoting migration and invasion of hypoxic breast cancer cells was demonstrated by our experimental evidence. Mechanistically, MRPL52 promoted PTEN-induced putative kinase 1 /Parkin-dependent mitophagy to remove oxidatively damaged mitochondria and prevent uncontrolled reactive oxygen species (ROS) generation, thus repressing activation of the mitochondrial apoptotic cascade. Additionally, MRPL52 augmented epithelial-mesenchymal transition, migration and invasion of hypoxic breast cancer cells by activating the ROS-Notch1-Snail signaling pathway. Benefited from this bidirectional regulatory mechanism, MRPL52 is responsible for maintaining ROS levels in a window that can induce tumorigenic signal transduction without causing cytotoxicity in hypoxic breast cancer cells. Conclusions: This work elucidates the molecular mechanism by which MRPL52 mediates hypoxia-induced apoptotic resistance and metastatic initiation of breast cancer, and provides new insights into the interplay between cancer and the tumor microenvironment.

Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis

Hypoxia Promotes Ectopic Adhesion Ability of Endometrial Stromal Cells Via TGF-β1/Smad Signaling in Endometriosis

Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation

Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer Therapy

Breast Cancer Cells Induce Stromal Fibroblasts To Secrete Adamts1 For Cancer Invasion Through An Epigenetic Change

Hypoxia Selectively Enhances Integrin α5β1 Receptor Expression in Breast Cancer to Promote Metastasis

Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of ΔNp63α expression and promote breast cancer metastasis independent of HIF1α

HIF-1-induced mitochondrial ribosome protein L52: a mechanism for breast cancer cellular adaptation and metastatic initiation in response to hypoxia

HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer

Implications of Hypoxia in Breast Cancer Metastasis to Bone

The HIF target MAFF promotes tumor invasion and metastasis through IL11 and STAT3 signaling

HIF-1α knockdown suppresses breast cancer metastasis via epithelial mesenchymal transition Abrogation

ZC3H12A inhibits tumor growth and metastasis of breast cancer under hypoxic condition via the inactivation of IL-17 signaling pathway

Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression

TGF-β and RAS jointly unmask primed enhancers to drive metastasis

Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment

Extracellular ATP promotes breast cancer invasion and epithelial‐mesenchymal transition via hypoxia‐inducible factor 2α signaling

HIF‐1α Binding to AEG‐1 Promoter Induced Upregulated AEG‐1 Expression Associated with Metastasis in Ovarian Cancer

Hypoxia Induces Epithelial-Mesenchymal Transition Via Activation of SNAI1 by Hypoxia-Inducible Factor -1Α in Hepatocellular Carcinoma.

Hypoxia Induces Growth Differentiation Factor 15 to Promote the Metastasis of Colorectal Cancer Via PERK-eIF2α Signaling.

Data from Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis